Arvidsson M B, Löwhagen O, Rak S
Asthma and Allergy Research Group, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Göteborg, Sweden.
Allergy. 2007 May;62(5):488-94. doi: 10.1111/j.1398-9995.2007.01278.x.
Standardized experimental allergen challenges are usually adopted to investigate the effect of allergen exposure on the lower airways. Environmental (natural) allergen challenges are used less often, mainly because of difficulties in standardizing the method, safety reasons and costs. The aim of this study was to investigate the relationship between an experimental and an environmental bronchial challenge. For this reason a natural challenge model was developed.
Sixty-two patients with a history of cat allergen-induced symptoms involving the lower airways, positive skin prick test, positive in vitro specific IgE to cat allergen and bronchial hyper-responsiveness were included. All 62 patients underwent an experimental challenge in the laboratory followed by an environmental allergen challenge.
All 62 patients developed an early asthmatic response [>or=20% fall in forced expiratory volume in 1 s (FEV1)] in the experimental challenge and 60% (37/62) during the environmental challenge. A late asthmatic response (>or=15% fall in FEV1 within 3-24 h) was seen in 56% (35/62) of the patients after the experimental challenge. Following the environmental challenge 47% (29/62) of the patients developed a late response. Thirty-four per cent (21/62) of the patients developed a late response in both challenge models and 31% (19/62) did not develop a late response in any model. Thus, there was consistency in 65% (40/62) of the patients in both challenge models.
We found consistency in the pattern of response to inhaled allergen between the two challenge models and we believe that experimental bronchial challenge is likely to reflect the development of relevant inflammation in the lower airways after low-dose allergen exposure in the environment.
标准化实验性过敏原激发试验通常用于研究过敏原暴露对下呼吸道的影响。环境(自然)过敏原激发试验较少使用,主要是因为方法标准化存在困难、安全原因及成本问题。本研究的目的是调查实验性支气管激发试验与环境支气管激发试验之间的关系。因此开发了一种自然激发模型。
纳入62例有猫过敏原诱发下呼吸道症状病史、皮肤点刺试验阳性、体外针对猫过敏原的特异性IgE阳性且有支气管高反应性的患者。所有62例患者先在实验室进行实验性激发试验,随后进行环境过敏原激发试验。
所有62例患者在实验性激发试验中均出现早期哮喘反应[第1秒用力呼气容积(FEV1)下降≥20%],在环境激发试验中有60%(37/62)出现该反应。56%(35/62)的患者在实验性激发试验后出现迟发性哮喘反应(3 - 24小时内FEV1下降≥15%)。在环境激发试验后,47%(29/62)的患者出现迟发性反应。34%(21/62)的患者在两种激发模型中均出现迟发性反应,31%(19/62)的患者在任何模型中均未出现迟发性反应。因此,两种激发模型中65%(40/62)的患者反应模式一致。
我们发现两种激发模型对吸入性过敏原的反应模式具有一致性,并且我们认为实验性支气管激发试验可能反映了环境中低剂量过敏原暴露后下呼吸道相关炎症的发展情况。